Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9257 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8805 |
High Similarity |
NPD6959 |
Discontinued |
0.8782 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8693 |
High Similarity |
NPD1512 |
Approved |
0.8642 |
High Similarity |
NPD6166 |
Phase 2 |
0.8642 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8642 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD7075 |
Discontinued |
0.8608 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.859 |
High Similarity |
NPD4380 |
Phase 2 |
0.8562 |
High Similarity |
NPD1511 |
Approved |
0.8544 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8533 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8481 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8477 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8443 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8418 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.84 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8393 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8389 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8383 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8373 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8272 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8255 |
Intermediate Similarity |
NPD1240 |
Approved |
0.825 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8224 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8224 |
Intermediate Similarity |
NPD6099 |
Approved |
0.821 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8193 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8125 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8049 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7935 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7922 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7834 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7815 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7806 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7763 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD920 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD919 |
Approved |
0.7657 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7593 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7581 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7581 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7581 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD943 |
Approved |
0.7544 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7544 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7543 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7527 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7514 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7453 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7446 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD3268 |
Approved |
0.741 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD411 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7277 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD7874 |
Approved |
0.725 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7243 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7204 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7173 |
Intermediate Similarity |
NPD8319 |
Approved |
0.717 |
Intermediate Similarity |
NPD447 |
Suspended |
0.717 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD3972 |
Approved |
0.712 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7062 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7039 |
Intermediate Similarity |
NPD17 |
Approved |
0.7035 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7025
|
Intermediate Similarity |
NPD7095 |
Approved |